https://www.selleckchem.com/pr....oducts/pf-03084014-p
Higher fibroblast growth factor-23 (FGF23) concentrations are associated with heart failure and mortality in diverse populations, but the strengths of associations differ markedly depending up on which assay is used. We sought to evaluate whether iron deficiency, inflammation, or kidney function account for differences in the strengths of associations between these 2 FGF23 assays with clinical outcomes. Case cohort study from the Cardiovascular Health Study. A total of 844 community-dwelling individuals aged 65 years or o
पसंद करना
टिप्पणी
शेयर करना
